- Joined
- Feb 8, 2004
- Messages
- 8,026
- Reaction score
- 4,154
Back in March 2020 the DEA relaxed regulations for drug testing with Buprenorphine. It allowed for more telemedicine, less in person visits and less testing.
Well it's been over a year and I don't see any updates. I've looked at the SAMHSA websites and don't see any. If anything more relaxation occurred. Now I'm getting paranoid that they've made new regulations or restarted prior regulations that I'm not aware.
I'm going to give SAMHSA a call this coming Monday. Anyone know of any new updates more recent than 6 months? Are any regulations back up?
Well it's been over a year and I don't see any updates. I've looked at the SAMHSA websites and don't see any. If anything more relaxation occurred. Now I'm getting paranoid that they've made new regulations or restarted prior regulations that I'm not aware.
I'm going to give SAMHSA a call this coming Monday. Anyone know of any new updates more recent than 6 months? Are any regulations back up?